ZWEITMALIGNOME NACH ERFOLGREICH THERAPIERTEM MORBUS HODGKIN

Translated title of the contribution: Secondary malignancies after successful treatment of Hodgkin's disease

S. Fries, R. Munker, E. Hiller, W. Wilmanns, H. Dietzfelbinger

Research output: Contribution to journalArticlepeer-review

Abstract

Due to advances in chemo- and radiation therapy Hodgkin's disease has become a potentially curable disease. Secondary malignancies after successful treatment of Hodgkin's disease are an important late event. The question has to be asked how many of the second tumors are treatment-related, or if these patients show a genetic predisposition to develop malignant tumors. The study presented here is part of an investigation supported by the W. Vaillant foundation. Patients with secondary malignancies are analysed and risk factors will be defined. We present 142 patients with Hodgkin's disease treated between June 1961 and June 1993. 14 of 142 patients developed a secondary malignancy during a mean follow-up time of 9.6 years. 10 years after diagnosis of Hodgkin's disease there was a cumulative frequency of 6%, and after 20 years of 20%. Solid tumors of different histologic origin and leukemias were observed.

Translated title of the contributionSecondary malignancies after successful treatment of Hodgkin's disease
Original languageGerman
Pages (from-to)169-171
Number of pages3
JournalMunchener Medizinische Wochenschrift
Volume138
Issue number10
StatePublished - 1996

Keywords

  • (following) treatment
  • Hodgkin's disease
  • secondary malignancies

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Secondary malignancies after successful treatment of Hodgkin's disease'. Together they form a unique fingerprint.

Cite this